Chinese pharmaceutical company North China Pharmaceutical has announced the completion of a public offering of ten million short-term bonds to raise CNY1bn ($146.93m).

Priced at CNY100 ($14.69) each, the bonds are due 3 April 2018 and carry a rate of 5.3%.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Arena Pharmaceuticals has announced an underwritten public offering of common stock shares to raise $150m.

The US-based biopharmaceutical company plans to use the funds towards the clinical and pre-clinical development of its drug candidates.

"Arena Pharmaceuticals has announced an underwritten public offering of common stock shares to raise $150m."

Enterome Bioscience and Nestle’s subsidiary Nestle Health Science have announced the formation of a joint venture named Microbiome Diagnostics Partners (MDP).

The JV company will be engaged in the discovery, development and commercialisation of diagnostics in multiple disease areas.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Enterome is a drug development company based in France, while Nestle Health Science is a US-based health science company.

Pharmaceutical Technology Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Pharmaceutical Technology Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now